Description of clinical profile, acute complications and glycemic control after Ramadan fasting in a Tunisian population of patients with diabetes

IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM

Human Nutrition and Metabolism Pub Date : 2024-07-30 DOI:10.1016/j.hnm.2024.200285

Chaima Jemai , Mariem Nouira , Yosra Htira , Zohra Hadj Ali , Faika Ben Mami

{"title":"Description of clinical profile, acute complications and glycemic control after Ramadan fasting in a Tunisian population of patients with diabetes","authors":"Chaima Jemai , Mariem Nouira , Yosra Htira , Zohra Hadj Ali , Faika Ben Mami","doi":"10.1016/j.hnm.2024.200285","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>To assess clinical and metabolic parameters in patients with diabetes during Ramadan fasting.</p></div><div><h3>Patients and method</h3><p>It was a prospective evaluative study based in the National Institute of Nutrition of Tunis (Departement C) in a population of patients with diabetes prepared for fasting by education and therapeutic adjustment.</p></div><div><h3>Results</h3><p>140 diabetics, mainly at high and very high risk (70.7 %), were analyzed. The frequencies of hypo and hyperglycemia were 12.1 and 11.4 % respectively. The mean weight and the mean systolic and diastolic blood pressure remained stable. Fasting blood glucose and HbA1C decreased significantly (−0.7 ± 3.1 mmol/L (p = 0.009), −0.18 ± 1.1 % (p = 0.047). The mean creatinine clearance had remained stable.</p></div><div><h3>Conclusion</h3><p>Ramadan fasting can be well-tolerated, even for patients at high and very high risk, with an improvement in glycemic control, provided prior education and adequate therapeutic adjustment.</p></div>","PeriodicalId":36125,"journal":{"name":"Human Nutrition and Metabolism","volume":"38 ","pages":"Article 200285"},"PeriodicalIF":1.9000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666149724000471/pdfft?md5=7181051fa2e23faa734058a3c42fb0fa&pid=1-s2.0-S2666149724000471-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Nutrition and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666149724000471","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

To assess clinical and metabolic parameters in patients with diabetes during Ramadan fasting.

Patients and method

It was a prospective evaluative study based in the National Institute of Nutrition of Tunis (Departement C) in a population of patients with diabetes prepared for fasting by education and therapeutic adjustment.

Results

140 diabetics, mainly at high and very high risk (70.7 %), were analyzed. The frequencies of hypo and hyperglycemia were 12.1 and 11.4 % respectively. The mean weight and the mean systolic and diastolic blood pressure remained stable. Fasting blood glucose and HbA1C decreased significantly (−0.7 ± 3.1 mmol/L (p = 0.009), −0.18 ± 1.1 % (p = 0.047). The mean creatinine clearance had remained stable.

Conclusion

Ramadan fasting can be well-tolerated, even for patients at high and very high risk, with an improvement in glycemic control, provided prior education and adequate therapeutic adjustment.

查看原文本刊更多论文

描述突尼斯糖尿病患者斋月禁食后的临床概况、急性并发症和血糖控制情况

目的评估斋月禁食期间糖尿病患者的临床和代谢参数。患者和方法这是突尼斯国家营养研究所（C 部）的一项前瞻性评估研究，研究对象是通过教育和治疗调整做好禁食准备的糖尿病患者。血糖过低和过高的比例分别为 12.1% 和 11.4%。平均体重、平均收缩压和舒张压保持稳定。空腹血糖和 HbA1C 显著下降（-0.7 ± 3.1 mmol/L (p = 0.009)、-0.18 ± 1.1 % (p = 0.047)）。结论：如果事先进行教育和适当的治疗调整，即使是高风险和极高风险患者也能很好地耐受拉马丹禁食，并改善血糖控制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Human Nutrition and Metabolism Agricultural and Biological Sciences-Food Science

CiteScore

1.50

自引率

0.00%

发文量

审稿时长

188 days